Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.04 (market cap $1.74B), while Roivant Sciences Ltd. Common Shares trades at $35.08 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 14.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| NUVB | ROIV | |
|---|---|---|
Market Cap | $1.74B | $24.72B |
Volume | 9,289,619 | 6,279,442 |
Sector | Health | Health |
52-Week High | $9.54 | $41.81 |
52-Week Low | $3.41 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.33B | $20.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
